Drug Abuse Antibodies

Globalization, reduced cost, increased availability and new designer drugs have all contributed to a significant increase in abuse of illegal and controlled drugs in recent years. It was estimated that a total of 246 million people worldwide – slightly over 5% of those aged 15 to 64 years – used an illicit drug in 2013, with some 27 million of these people classified as problem drug users (World Drug Report 2015). This increased consumption is having a significant impact on healthcare systems and to society in general, leading to new government initiatives to try and control and monitor the problem.

All of these factors are fueling the growth of the Drugs of Abuse testing market, which is forecast to grow at 9.8% per year over the next 5 years and be worth $9.1B by 2023 (P&S Market Research, Sept 2017). The increased demand for tests is driven by law enforcement, workplace screening programs, rehabilition/addiction centers, hospitals, and private/home testing. In addition, the legalization of marijuana in parts of the United States and across Canada is expected to intensify the demand for tests from law enforcement as they enforce driving under the influence laws.

As a leader in providing diagnostic antibodies and reagents to IVD developers and manufacturers, we have assembled a classic panel of antibodies, paired against the most important Drug of Abuse targets. The antibodies are available in bulk and designed to meet the immediate needs of an IVD manufacturing environment.

Features & benefits

• Quality
• Sensitivity
• Specificity
• Validated pairs
• Lot-to-lot consistency
• Bulk availability
• Volume-based pricing

Back to Top